Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis
Jianbo Zhou, Xingyao Tang, Min Han, et al.
Metabolism (2020) Vol. 109, pp. 154265-154265
Open Access | Times Cited: 80

Showing 26-50 of 80 citing articles:

Microbiome–metabolomics analysis reveals the potential effect of verbascoside in alleviating cognitive impairment in db/db mice
Ran Zheng, Bowei Ju, Lin Cao, et al.
Food & Function (2023) Vol. 14, Iss. 8, pp. 3488-3508
Closed Access | Times Cited: 18
Repositioning of Anti-Diabetic Drugs against Dementia: Insight from Molecular Perspectives to Clinical Trials
Keren Esther Kristina Mantik, Sujin Kim, Bonsang Gu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11450-11450
Open Access | Times Cited: 17
Promising use of metformin in treating neurological disorders: biomarker-guided therapies
Allison Loan, Charvi Syal, Margarita Lui, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 5, pp. 1045-1055
Open Access | Times Cited: 17
Thiazolidinedione use is associated with reduced risk of dementia in patients with type 2 diabetes mellitus: A retrospective cohort study
Houyu Zhao, Lin Zhuo, Yexiang Sun, et al.
Journal of Diabetes (2023) Vol. 15, Iss. 2, pp. 97-109
Open Access | Times Cited: 16
Looking for the philosopher's stone: Emerging approaches to target the hallmarks of aging in the skin
Jean-Marc Lemaı̂tre
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. S4, pp. 5-14
Open Access | Times Cited: 7
Neuroprotective effects of dipeptidyl peptidase 4 inhibitor on Alzheimer’s disease: a narrative review
Xin Jiang, Ji Li, Xiaohui Yao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Novel strategies for glycaemic control and preventing diabetic complications applying the clustering-based classification of adult-onset diabetes mellitus: A perspective
Hayato Tanabe, Hiroaki Masuzaki, Michio Shimabukuro
Diabetes Research and Clinical Practice (2021) Vol. 180, pp. 109067-109067
Open Access | Times Cited: 40
The effect of metformin on cognitive function: A systematic review and meta-analysis
Ozra Tabatabaei‐Malazy, Fatemeh Bandarian, Mostafa Qorbani, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 6, pp. 666-679
Closed Access | Times Cited: 23
Association Between Metformin and Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Clinical Observational Studies
Anling Luo, Pingping Ning, Haitao Lu, et al.
Journal of Alzheimer s Disease (2022) Vol. 88, Iss. 4, pp. 1311-1323
Closed Access | Times Cited: 22
Molecular and neural roles of sodium-glucose cotransporter 2 inhibitors in alleviating neurocognitive impairment in diabetic mice
Iwona Piątkowska‐Chmiel, Mariola Herbet, Monika Gawrońska‐Grzywacz, et al.
Psychopharmacology (2023) Vol. 240, Iss. 4, pp. 983-1000
Open Access | Times Cited: 14
Repurposing and clinical attributes of antidiabetic drugs for the treatment of neurodegenerative disorders
Swapnali Vasant Birajdar, Farhan Mazahir, Md Imtiyaz Alam, et al.
European Journal of Pharmacology (2023) Vol. 961, pp. 176117-176117
Closed Access | Times Cited: 13
Risk of Dementia and Alzheimer's Disease Associated With Antidiabetics: A Bayesian Network Meta-Analysis
Yongjun Sunwoo, Jaeho Park, Chang-Young Choi, et al.
American Journal of Preventive Medicine (2024) Vol. 67, Iss. 3, pp. 434-443
Closed Access | Times Cited: 5
Effect of diabetes medications on the risk of developing dementia, mild cognitive impairment, or cognitive decline: A systematic review and meta-analysis
Esther K. Hui, Naaheed Mukadam, Gianna Kohl, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
Exploring the connection between dementia and cardiovascular risk with a focus on ADAM10
Ana Beatriz Aparecida Targas, Pedro Henrique Moreira Victoriano, M. Garcia, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167825-167825
Closed Access
Glycated hemoglobin and body mass index as mediators of GLP‐1RAs and Alzheimer's disease and related dementias in patients with type 2 diabetes
Huilin Tang, William T. Donahoo, Steven T. DeKosky, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 4
Open Access
Repositioning and development of new treatments for neurodegenerative diseases: Focus on neuroinflammation
Bruno Dutra Arbo, Lúcia Emanueli Schimith, Michele Goulart dos Santos, et al.
European Journal of Pharmacology (2022) Vol. 919, pp. 174800-174800
Open Access | Times Cited: 20
The development and benefits of metformin in various diseases
Ying Dong, Yingbei Qi, Haowen Jiang, et al.
Frontiers of Medicine (2023) Vol. 17, Iss. 3, pp. 388-431
Closed Access | Times Cited: 12
Incident dementia risk among patients with type 2 diabetes receiving metformin versus alternative oral glucose-lowering therapy: an observational cohort study using UK primary healthcare records
William T. Doran, Louis Tunnicliffe, Rutendo Muzambi, et al.
BMJ Open Diabetes Research & Care (2024) Vol. 12, Iss. 1, pp. e003548-e003548
Open Access | Times Cited: 4
Association of sodium‐glucose cotransporter 2 inhibitors with risk of incident dementia and all‐cause mortality in older patients with type 2 diabetes: A retrospective cohort study using the TriNetX US collaborative networks
Yen‐Wei Pai, I‐Chieh Chen, Jun‐Fu Lin, et al.
Diabetes Obesity and Metabolism (2024)
Closed Access | Times Cited: 4
Metformin and the risk of neurodegenerative diseases in patients with diabetes: A meta‐analysis of population‐based cohort studies
Yunnan Zhang, Yi Zhang, Xiujin Shi, et al.
Diabetic Medicine (2022) Vol. 39, Iss. 6
Closed Access | Times Cited: 16
Sex-specific associations between diabetes and dementia: the role of age at onset of disease, insulin use and complications
Chunmiao Zhou, Caiyun Dong, Ziwei Xie, et al.
Biology of Sex Differences (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 10
Metformin: The Winding Path from Understanding Its Molecular Mechanisms to Proving Therapeutic Benefits in Neurodegenerative Disorders
Laura Mihaela Isop, Andrea Elena Neculau, Radu Necula, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1714-1714
Open Access | Times Cited: 10
Dipeptidyl peptidase 4(DPP4) inhibitors stride up the management of Parkinson's disease
Maanvi, Shilpa Kumari, Rahul Deshmukh
European Journal of Pharmacology (2022) Vol. 939, pp. 175426-175426
Closed Access | Times Cited: 14
Exploring the Potential of Antidiabetic Agents as Therapeutic Approaches for Alzheimer's and Parkinson's Diseases: A Comprehensive Review
Mahima Koshatwar, Sourya Acharya, Roshan Prasad, et al.
Cureus (2023)
Open Access | Times Cited: 8
Insights from insulin resistance pathways: Therapeutic approaches against Alzheimer associated diabetes mellitus
Ayesha Fauzi, Ewen Se Thoe, Yin-Quan Tang, et al.
Journal of Diabetes and its Complications (2023) Vol. 37, Iss. 11, pp. 108629-108629
Closed Access | Times Cited: 8

Scroll to top